GQG Partners’s Celgene Corp CELG Stock Holding History

GQG Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-443,655	Closed	-$64.7M	–	62
2017 Q3	$64.7M	Buy	443,655 +281,629	+174%	+$38.4M	2.27%	18
2017 Q2	$21M	Buy	+162,026	New	+$19.9M	1.55%	26

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

GQG Partners's CELG Position: Q4 2017 in Review

GQG Partners sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 443,655 shares — an estimated $64.7M sold.

GQG Partners first reported a position in CELG in Q2 2017 and held it in 2 quarters. The position peaked at $64.7M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

GQG Partners reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
GQG Partners sold 443,655 Celgene Corp shares in Q4 2017, an estimated $64.7M.
GQG Partners first reported a position in Celgene Corp in Q2 2017 and held it in 2 quarters.
GQG Partners's Celgene Corp position peaked at $64.7M in Q3 2017.
1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on GQG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.